Walker Chase, Little Virna, Joyner Jian, Fuller Steven, Green Brandn
Research Department, JG Research and Evaluation, Bozeman, Montana, United States.
Research Department, Concert Health, San Diego, California, United States.
J Family Med Prim Care. 2024 May;13(5):1968-1974. doi: 10.4103/jfmpc.jfmpc_1493_23. Epub 2024 May 24.
In the United States, access to evidence-based behavioral health treatment remains limited, contributing to inadequate treatment for individuals with depression and anxiety disorders. The Collaborative care model (CoCM), the integration of behavioral healthcare into primary care, has been shown to be effective in addressing this issue, particularly when delivered virtually through telehealth platforms. While collaborative care has been shown to be effective, little has been studied to understand the impact of patient treatment factors on patient improvement. This study aims to analyze factors associated with patient improvement, measured by PHQ-9 and GAD-7 score changes, in patients with depression and anxiety disorders from Concert Health, a national behavioral medical group offering collaborative care across 18 states.
Stepwise logistic regression models were utilized to identify factors influencing patient improvement in standardized symptom screener scores (PHQ-9 and GAD-7). Relevant patient-level data, including demographics, clinical engagement, insurance type, clinical touchpoints, and other variables, were analyzed. Results are presented as odds ratios (ORs).
We find that increased clinical touchpoints were associated with improved outcomes in both depression (PHQ-9) and anxiety (GAD-7) populations. Commercial insurance was linked to a greater likelihood of improvement relative to Medicaid, and the use of C-SSRS suicide screeners had varied effects on patient outcomes depending on the diagnosis. The duration of time spent in appointments showed a nuanced impact, suggesting an optimal length for touchpoints. Psychiatric consults also impact patient outcomes in both populations. This study sheds light on factors influencing patient outcomes in virtual collaborative care for depression and anxiety disorders, which may be used to inform and motivate further research and allow providers to better optimize and understand the impacts of treatment choices in collaborative care settings.
在美国,获得循证行为健康治疗的机会仍然有限,这导致抑郁症和焦虑症患者的治疗不足。协作护理模式(CoCM),即将行为医疗保健整合到初级保健中,已被证明在解决这一问题方面是有效的,特别是通过远程医疗平台进行虚拟提供时。虽然协作护理已被证明是有效的,但很少有研究了解患者治疗因素对患者改善的影响。本研究旨在分析与患者改善相关的因素,通过PHQ-9和GAD-7评分变化来衡量,这些患者来自Concert Health,这是一家在18个州提供协作护理的全国性行为医疗集团,患有抑郁症和焦虑症。
采用逐步逻辑回归模型来识别影响标准化症状筛查分数(PHQ-9和GAD-7)患者改善的因素。分析了相关的患者层面数据,包括人口统计学、临床参与度、保险类型、临床接触点和其他变量。结果以比值比(OR)表示。
我们发现,增加临床接触点与抑郁症(PHQ-9)和焦虑症(GAD-7)人群的改善结果相关。相对于医疗补助,商业保险与更大的改善可能性相关,并且使用C-SSRS自杀筛查工具对患者结果的影响因诊断而异。预约花费的时间长度显示出细微的影响,表明接触点有一个最佳长度。精神科会诊也会影响这两个人群的患者结果。本研究揭示了影响抑郁症和焦虑症虚拟协作护理中患者结果的因素,这可用于为进一步研究提供信息和激励,并使提供者能够更好地优化和理解协作护理环境中治疗选择的影响。